Skip to main navigation Skip to search Skip to main content

GATA3 induces mitochondrial biogenesis in primary human CD4+ T cells during DNA damage

  • Lauren A. Callender
  • , Johannes Schroth
  • , Elizabeth C. Carroll
  • , Conor Garrod-Ketchley
  • , Lisa E.L. Romano
  • , Eleanor Hendy
  • , Audrey Kelly
  • , Paul Lavender
  • , Arne N. Akbar
  • , J. Paul Chapple
  • , Sian M. Henson
    • Barts and The London School of Medicine and Dentistry
    • Achilles Therapeutics Ltd
    • King's College London
    • University College London

    Research output: Contribution to journalArticlepeer-review

    30 Citations (Scopus)

    Abstract

    GATA3 is as a lineage-specific transcription factor that drives the differentiation of CD4+ T helper 2 (Th2) cells, but is also involved in a variety of processes such as immune regulation, proliferation and maintenance in other T cell and non-T cell lineages. Here we show a mechanism utilised by CD4+ T cells to increase mitochondrial mass in response to DNA damage through the actions of GATA3 and AMPK. Activated AMPK increases expression of PPARG coactivator 1 alpha (PPARGC1A or PGC1α protein) at the level of transcription and GATA3 at the level of translation, while DNA damage enhances expression of nuclear factor erythroid 2-related factor 2 (NFE2L2 or NRF2). PGC1α, GATA3 and NRF2 complex together with the ATR to promote mitochondrial biogenesis. These findings extend the pleotropic interactions of GATA3 and highlight the potential for GATA3-targeted cell manipulation for intervention in CD4+ T cell viability and function after DNA damage.

    Original languageEnglish
    Article number3379
    JournalNature Communications
    Volume12
    Issue number1
    DOIs
    Publication statusPublished - 1 Dec 2021

    Fingerprint

    Dive into the research topics of 'GATA3 induces mitochondrial biogenesis in primary human CD4+ T cells during DNA damage'. Together they form a unique fingerprint.

    Cite this